Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Huddart

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 14, 2017
The National Institute for Health and Care Excellence (NICE) Guidance on Bladder Cancer; a Step in the Right Direction?S Trainor, A Choudhury, R Huddart, et al.
American Journal of Medical Genetics|April 23, 1999
Familial ovarian germ cell cancer: report and reviewA R Stettner, E M Hartenbach, J C Schink, et al.
British Journal of Cancer|November 23, 2013
Second cancer risk and mortality in men treated with radiotherapy for stage I seminomaA Horwich, S D Fossa, R Huddart, et al.
Oncology|July 8, 2011
Brief report: phase II multicenter study of temozolomide in patients with cisplatin-resistant germ cell tumorsP Maroto, R Huddart, X Garcia del Muro, et al.
Clinical Radiology|March 7, 2009
Prospective assessment of MRI for imaging retroperitoneal metastases from testicular germ cell tumoursS A Sohaib, D M Koh, Y Barbachano, et al.
Journal of Medical Genetics|May 5, 1999
Familial testicular cancer: lack of evidence for trinucleotide repeat expansions and association with PKD1 in one familyB T Teh, K Linblad, B Nord, et al.
Clinical and Translational Radiation Oncology|September 1, 2021
A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancerR Portner, A Bajaj, T Elumalai, et al.
British Journal of Cancer|July 25, 2013
Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-upA Creak, E Hall, A Horwich, et al.
British Journal of Cancer|July 7, 2005
A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trialG M Mead, M H Cullen, R Huddart, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 28, 2017
Upfront Docetaxel in the Post-STAMPEDE World: Lessons from an Early Evaluation of Non-trial Usage in Hormone-Sensitive Prostate CancerA Patrikidou, M Uccello, A Tree, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 14, 2017
The National Institute for Health and Care Excellence (NICE) Guidance on Bladder Cancer; a Step in the Right Direction?S Trainor, A Choudhury, R Huddart, et al.
American Journal of Medical Genetics|April 23, 1999
Familial ovarian germ cell cancer: report and reviewA R Stettner, E M Hartenbach, J C Schink, et al.
British Journal of Cancer|November 23, 2013
Second cancer risk and mortality in men treated with radiotherapy for stage I seminomaA Horwich, S D Fossa, R Huddart, et al.
Oncology|July 8, 2011
Brief report: phase II multicenter study of temozolomide in patients with cisplatin-resistant germ cell tumorsP Maroto, R Huddart, X Garcia del Muro, et al.
Clinical Radiology|March 7, 2009
Prospective assessment of MRI for imaging retroperitoneal metastases from testicular germ cell tumoursS A Sohaib, D M Koh, Y Barbachano, et al.
Journal of Medical Genetics|May 5, 1999
Familial testicular cancer: lack of evidence for trinucleotide repeat expansions and association with PKD1 in one familyB T Teh, K Linblad, B Nord, et al.
Clinical and Translational Radiation Oncology|September 1, 2021
A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancerR Portner, A Bajaj, T Elumalai, et al.
British Journal of Cancer|July 25, 2013
Randomised pilot study of dose escalation using conformal radiotherapy in prostate cancer: long-term follow-upA Creak, E Hall, A Horwich, et al.
British Journal of Cancer|July 7, 2005
A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trialG M Mead, M H Cullen, R Huddart, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 28, 2017
Upfront Docetaxel in the Post-STAMPEDE World: Lessons from an Early Evaluation of Non-trial Usage in Hormone-Sensitive Prostate CancerA Patrikidou, M Uccello, A Tree, et al.
Pageof 9